Genetix on a slippery SlidePath

Genetix Group plc, a Hampshire-based cell imaging and analysis group, has acquired SlidePath Limited, a Dublin-based telepathology and bioinformatics company for up to £3.3 million. 


Genetix Group plc, a Hampshire-based cell imaging and analysis group, has acquired SlidePath Limited, a Dublin-based telepathology and bioinformatics company for up to £3.3 million. 

Genetix Group plc, a Hampshire-based cell imaging and analysis group, has acquired SlidePath Limited, a Dublin-based telepathology and bioinformatics company for up to £3.3 million.

Digital pathology is the computer-enabled management and interpretation of pathology information generated from slides. SlidePath is a Dublin City University spin out, which was founded in 2003 and has 25 employees. The company reported revenues of €1.3 million (£1.2 million) with a pre-tax loss of €500,000 (£448,000).

Charles de Rohan, chief executive of Genetix, said: “This transaction brings together two companies with highly complementary core skills that will greatly strengthen our competitive position in the growing digital pathology market.”

Nick Britton

Nick Britton

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics

Early Stage Funding